Ng George K 4/A
4/A · Processa Pharmaceuticals, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4/AAmended
Ng George K
DirectorChief Executive Officer
Transactions
- Award
Warrants
2025-01-29+87,200→ 87,200 total(indirect: George Ng IRRA FBO: George Ng)Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (87,200 underlying) - Award
Warrants
2025-01-29+43,600→ 43,600 total(indirect: George Ng IRRA FBO: George Ng)Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (43,600 underlying)
Holdings
- 87,200(indirect: George Ng IRRA FBO: George Ng)
Common Stock
- 20,000(indirect: By Trust)
Common Stock